Search results
Better Than Ozempic? Doctors Say These Medications Are Better for Weight Loss Than the Popular...
Woman's World via Yahoo News· 2 days agoIn fact, this is the only use for which the medication is FDA-approved. Since the drug helps to...
Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP.
The Wall Street Journal· 2 days agoRetatrutide is still in Phase 3 trials and won’t be up for FDA approval for a few years. If it...
Abortion pill’s hazy legal future
Politico· 1 day ago“Under that decision, mifepristone remains available under the conditions of use approved by FDA.” IT’S FRIDAY. WELCOME BACK TO PRESCRIPTION PULSE...the ...
Jesse Plemons Addresses Ozempic Rumors Amid Weight Loss Journey
E! News via Yahoo News· 2 days agoBreaking Bad actor Jesse Plemons cleared the air about his weight loss, shutting down speculation...
Pre-diabetes rates increase amidst a renaissance for type 2 diabetes research
Pharmaceutical Technology via Yahoo Finance· 1 day agoAstraZeneca received US Food and Drug Administration (FDA) approval earlier this week for its...
Eli Lilly Runs Up 49% With Expectations For Weight-Loss Sales To Triple
Investor's Business Daily· 4 days agoRevenue from Eli Lilly's weight-loss drug is expected to triple over the next five years to over $50...
Vaxart Bags $453M Worth BARDA-Funded Project, Seeks To Raise $40M Via Equity Offering
Benzinga· 1 day agoVaxart, Inc. VXRT shares traded higher in the premarket session on Friday, up more than 23% at one point. Vaxart’s average session volume was about 1.6 million. Yesterday, Vaxart obtained a ...
Prescriptions for drugs like Ozempic are soaring, and so is misinformation. Here is how to separate...
Eyewitness News Memphis· 5 days agoAccording to a study from Epic Research, prescriptions for drugs containing semaglutides (the main ingredient in drugs like Ozempic) have gone up 930% in four years. According to the Mayo Clinic ...
Hims vs. Keeps: Which Hair Growth Subscription Service is Right for You?
Men's Journal· 4 days agoKeeps and Hims are two popular telehealth companies that offer hair loss treatments for men. There...
Lilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients...
StreetInsider· 7 days agoEli Lilly and Company (NYSE: LLY) announced detailed results from SYNERGY-NASH, a phase 2 study of 190 patients, with or without type 2 diabetes, to evaluate the investigational use of tirzepatide ...
